Covid-19 vaccine trials start in SA; Aspen can cope with Covid-19 wonder drug demand; SAA; CR infrastructure spend

Loading player...
In today's news headlines:
* The first clinical trial in South Africa and on the continent for a Covid-19 vaccine begins this week. The vaccine is already being evaluated in a large clinical trial in the UK where more than 4,000 participants have already been enrolled;
* South African pharmaceutical maker Aspen could provide 10 million dexamethasone tablets within a month, CEO Stephen Saad;
* South Africa’s unemployment rate rose to a 17-year high in the first quarter, even before the full impact was felt of the Covid-19 lockdown;
* President Cyril Ramaphosa says the government will galvanise R2.3bn in infrastructure investment to create about 1.8m jobs over the next decade; and
* The South African government said on Tuesday it had received unsolicited proposals from private sector funders, private equity investors and potential partners for a new national airline based on SAA. Learn more about your ad choices. Visit megaphone.fm/adchoices
23 Jun 2020 3PM English South Africa Investing · Business News

Other recent episodes

Magnus Heystek: Why SA’s middle class is quietly being crushed

South Africans are being told everything is fine. Magnus Heystek says it’s a dangerous illusion. In a wide-ranging conversation with Alec Hogg, the veteran investment strategist warns that falling GDP per capita, rising taxes, weak property returns and flawed retirement structures are steadily hollowing out the middle class. From Regulation…
9 Jan 6AM 41 min

South Africa’s business titans are gone – and David Shapiro explains why

From Brian Joffe to Raymond Ackerman, South Africa once produced business giants who shaped the economy. David Shapiro argues they have been replaced by spreadsheet managers, over-regulation and compliance paralysis, and explains what that loss means for growth, risk-taking and the country’s future.
8 Jan 6AM 54 min